Is CBD Legal in Poland?
May 29, 2026
CBD is legal in Poland when sourced from hemp under 0.3% THC, but ingestible CBD is treated as a novel food and needs EU pre-market authorisation.
CBD is legal in Poland when sourced from hemp under 0.3% THC, but ingestible CBD is treated as a novel food and needs EU pre-market authorisation.
CBD is legal to sell in Poland when it is derived from industrial hemp and contains no more than 0.3% THC, the limit set under the 2022 amendment to the Drug Prevention Act. Pure CBD itself is not listed as a narcotic in the Annexes to the Drug Prevention Act, so isolates and full-spectrum extracts can move through retail channels provided they comply with EU food, cosmetic, and pharmaceutical rules.
The catch sits at the food layer. The European Commission's Novel Food Catalogue lists CBD extracts and isolated cannabinoids as novel foods under Regulation (EU) 2015/2283, which means any ingestible product needs pre-market authorisation. Poland's Główny Inspektorat Sanitarny (Sanepid) has used this position to challenge oils, gummies, and beverages sold as supplements, and several distributors have faced product seizures since 2023. CBD cosmetics fall under Regulation (EC) No 1223/2009 and are tolerated when notified through the CPNP. CBD-based medicinal products require URPL authorisation; Epidyolex is registered for specific epilepsy indications.
This page is for informational purposes only and does not constitute legal advice. Verify current law with qualified counsel before making compliance decisions.
Legal
Główny Inspektorat Sanitarny (Sanepid); Główny Inspektorat Farmaceutyczny (GIF); URPL
0.3% delta-9 THC in source hemp; trace levels permitted in finished products
Drug Prevention Act 2022 amendment (0.3% hemp THC limit); Regulation (EU) 2015/2283 on novel foods
CBD ingredients can be imported into Poland from other EU Member States under free-movement rules, but ingestible CBD products marketed as foods or supplements need a novel food authorisation under Regulation (EU) 2015/2283 before they can be sold. Sanepid checks import shipments and can withdraw products that lack authorisation. Cosmetic CBD products require CPNP notification, and pharmaceutical CBD requires a URPL marketing authorisation plus a GIF import permit.
